- Home
- CLRB vs LRFC Comparison
CLRB vs LRFC Comparison
Compare CLRB & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- LRFC
- Stock Information
- Founded
- CLRB 2002
- LRFC 2013
- Country
- CLRB United States
- LRFC United States
- Employees
- CLRB N/A
- LRFC N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- CLRB Health Care
- LRFC Finance
- Exchange
- CLRB Nasdaq
- LRFC Nasdaq
- Market Cap
- CLRB 17.6M
- LRFC 49.9M
- IPO Year
- CLRB N/A
- LRFC 2013
- Fundamental
- Price
- CLRB $4.78
- LRFC $19.08
- Analyst Decision
- CLRB Hold
- LRFC
- Analyst Count
- CLRB 2
- LRFC 0
- Target Price
- CLRB N/A
- LRFC N/A
- AVG Volume (30 Days)
- CLRB 166.2K
- LRFC 10.7K
- Earning Date
- CLRB 08-12-2025
- LRFC 08-07-2025
- Dividend Yield
- CLRB N/A
- LRFC 7.55%
- EPS Growth
- CLRB N/A
- LRFC N/A
- EPS
- CLRB N/A
- LRFC N/A
- Revenue
- CLRB N/A
- LRFC $20,544,000.00
- Revenue This Year
- CLRB N/A
- LRFC N/A
- Revenue Next Year
- CLRB N/A
- LRFC N/A
- P/E Ratio
- CLRB N/A
- LRFC N/A
- Revenue Growth
- CLRB N/A
- LRFC 3.11
- 52 Week Low
- CLRB $4.36
- LRFC $16.57
- 52 Week High
- CLRB $94.50
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- CLRB 33.97
- LRFC 60.72
- Support Level
- CLRB $4.62
- LRFC $18.55
- Resistance Level
- CLRB $5.17
- LRFC $19.24
- Average True Range (ATR)
- CLRB 0.74
- LRFC 0.30
- MACD
- CLRB -0.19
- LRFC 0.03
- Stochastic Oscillator
- CLRB 7.20
- LRFC 78.08
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.